Test Code MEVI Methemoglobinemia Interpretation
Useful For
Interpretation of the methemoglobinemia evaluation results
Diagnosis of methemoglobinemia and sulfhemoglobinemia and possible hereditary (congenital) causes
Differentiation of methemoglobinemia and sulfhemoglobinemia from other causes of cyanosis (eg, congenital heart disease)
Method Name
Only orderable as part of a profile. For more information see MEV1 / Methemoglobinemia Evaluation.
Medical Interpretation
Reporting Name
Methemoglobinemia InterpretationSpecimen Type
Whole Blood EDTASpecimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Whole Blood EDTA | Refrigerated | 72 hours |
Clinical Information
Methemoglobin:
Methemoglobin forms when the hemoglobin molecule iron is in the ferric (Fe[3+]) form instead of the functional ferrous (Fe[2+]) form. Methemoglobinemia can be hereditary or acquired and is present by definition when methemoglobin levels are greater than the normal range. Acquired methemoglobinemia results after toxic exposure to nitrates and nitrites/nitrates (fertilizer, nitric oxide), topical anesthetics (“caines"), dapsone, naphthalene (moth balls/toilet deodorant cakes), and industrial use of aromatic compounds (aniline dyes).
Congenital methemoglobinemias are rare. They are due either to:
-A deficiency of cytochrome b5 reductase (methemoglobin reductase) in erythrocytes, an autosomal recessive disorder resulting from genetic variants in either CYB5R3 or CYB5A genes.(1,2) Type IV is thought to be extraordinarily rare. Type III is no longer a category.
-One of several intrinsic structural disorders of hemoglobin, called M-hemoglobins (M-Hb), all of which are inherited in an autosomal dominant manner.(3,4) Classically, M-Hb result from histidine-to-tyrosine substitutions at the proximal or distal histidine important in coordinating the oxygen molecule. These include alpha-, beta- and gamma-chain variants. Rarely, other substitutions outside the proximal and distal histidine location can cause hemoglobin variants that increase methemoglobin or sulfhemoglobin levels. Most M-Hb variants are readily identified by high-performance liquid chromatography (HPLC) or mass spectrometry methods with characteristic electrophoresis patterns; however, some require more specialized techniques. Most are associated with increased methemoglobin, with or without an increase in sulfhemoglobin. Alpha chain M-Hb variants can be associated with increased sulfhemoglobin without an increase in methemoglobin.
Sulfhemoglobin:
Sulfhemoglobin cannot combine with oxygen. When acquired, sulfhemoglobinemia can be associated with cyanosis and often accompanies methemoglobinemia. Sulfhemoglobinemia has been associated with exposure to sumatriptan, sulfonamides, metoclopramide, paint or varnish vapors, dimethyl sulfoxide (DMSO), acetanilide, phenacetin, trinitroluene, zinc ethylene bisdithiocarbamate (a fungicide), and flutamide. It is important to note that some hemoglobin variants are known to interfere with this test (especially M-Hb), and sulfhemoglobin absorbance can be increased due to the hemoglobin variant. Hemoglobin evaluation that includes the HPLC method is recommended to exclude this possibility.
In contrast to methemoglobinemia, sulfhemoglobinemia persists until the erythrocytes containing it are destroyed. Therefore, blood level of sulfhemoglobin declines gradually over a period of weeks.
Reference Values
Only orderable as part of a profile. For more information see MEV1 / Methemoglobinemia Evaluation.
Definitive results and an interpretive report will be provided.
Performing Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
Not ApplicableCPT Code Information
83020-26
Day(s) Performed
Monday through Friday